Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease, Healthy Volunteer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01238458
What this trial is testing

Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 150
Very early researchStudy completedNCT01217021
What this trial is testing

Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 10
Early research (Phase 1)Study completedNCT00494962
What this trial is testing

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 40
Early research (Phase 1)Study completedNCT05804383
What this trial is testing

A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Allyx Therapeutics 51
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Early research (Phase 1)Study completedNCT00366483
What this trial is testing

Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 40
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Early research (Phase 1)Study completedNCT02392468
What this trial is testing

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Who this might be right for
SchizophreniaAlzheimer Disease
Boehringer Ingelheim 61
Not applicableLooking for participantsNCT07232459
What this trial is testing

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

Who this might be right for
AmyloidCardiac AmyloidosisAmyloidosis+1 more
Tianjin Medical University 25
Early research (Phase 1)Study completedNCT02291783
What this trial is testing

Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment

Who this might be right for
Alzheimer's Disease
Nxera Pharma UK Limited 108
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Early research (Phase 1)Ended earlyNCT02288000
What this trial is testing

Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseBattery
University Hospital, Lille 30
Early research (Phase 1)Study completedNCT00931073
What this trial is testing

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 24
Very early researchEnded earlyNCT02638519
What this trial is testing

HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Thunder Bay Regional Health Research Institute 51
Early research (Phase 1)Study completedNCT00439010
What this trial is testing

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05741060
What this trial is testing

Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers

Who this might be right for
Arterial StiffnessWhite Matter LesionsCognitive Decline
Akira Sekikawa 369
Not applicableStudy completedNCT06027320
What this trial is testing

The Retain Your Brain Health Study (RetainYourBrain.com)

Who this might be right for
Alzheimer DiseaseDementiaHealthy Participants+1 more
Retain Health, Inc 992
Early research (Phase 1)Ended earlyNCT01924858
What this trial is testing

A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 4
Early research (Phase 1)Study completedNCT03902548
What this trial is testing

Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Five Eleven Pharma, Inc. 14
Early research (Phase 1)Study completedNCT01807026
What this trial is testing

LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseHealthy Volunteers
Eli Lilly and Company 36
Next Page